FilingReader Intelligence
Bliss GVS Pharma reports annual meeting, dividend, and financials
July 9, 2025 at 03:00 PM UTC•By FilingReader AI
Bliss GVS Pharma has released its annual report for the financial year ended March 31, 2025, detailing its 40th Annual General Meeting, a proposed dividend, and key financial figures. The AGM is scheduled for July 31, 2025, conducted via video conferencing, and will address the adoption of financial statements, declaration of a final dividend of INR 0.50 per share, and the reappointment of Dr. Vibha Gagan Sharma as a director.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:BLISSGVS•Bombay Stock Exchange
News Alerts
Get instant email alerts when Bliss GVS Pharma publishes news
Free account required • Unsubscribe anytime